Envista (NVST) Projected to Post Earnings on Wednesday

Envista (NYSE:NVST) will likely be announcing its earnings results after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $0.23 per share and revenue of $646.28 million for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

Envista Trading Down 4.2 %

NYSE NVST opened at $20.51 on Monday. The business’s fifty day moving average is $20.08 and its 200 day moving average is $19.03. Envista has a twelve month low of $15.15 and a twelve month high of $24.79. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42. The company has a market cap of $3.53 billion, a price-to-earnings ratio of -2.64, a price-to-earnings-growth ratio of 1.89 and a beta of 1.33.

Analyst Upgrades and Downgrades

NVST has been the subject of a number of analyst reports. Mizuho assumed coverage on Envista in a report on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 price target for the company. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research report on Thursday, October 31st. Jefferies Financial Group increased their price objective on Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Wells Fargo & Company assumed coverage on Envista in a research report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 price objective on the stock. Finally, Piper Sandler raised their price target on Envista from $16.00 to $17.00 and gave the company a “neutral” rating in a research report on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $20.13.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.